Segui
Gabriele Trespidi
Gabriele Trespidi
Email verificata su unipv.it
Titolo
Citata da
Citata da
Anno
Burkholderia cenocepacia infections in cystic fibrosis patients: drug resistance and therapeutic approaches
VC Scoffone, LR Chiarelli, G Trespidi, M Mentasti, G Riccardi, S Buroni
Frontiers in microbiology 8, 293273, 2017
1592017
Quorum sensing as antivirulence target in cystic fibrosis pathogens
VC Scoffone, G Trespidi, LR Chiarelli, G Barbieri, S Buroni
International journal of molecular sciences 20 (8), 1838, 2019
702019
Role of RND efflux pumps in drug resistance of cystic fibrosis pathogens
VC Scoffone, G Trespidi, G Barbieri, S Irudal, E Perrin, S Buroni
Antibiotics 10 (7), 863, 2021
302021
Investigating the mechanism of action of diketopiperazines inhibitors of the Burkholderia cenocepacia quorum sensing synthase CepI: a site-directed mutagenesis study
S Buroni, VC Scoffone, M Fumagalli, V Makarov, M Cagnone, G Trespidi, ...
Frontiers in Pharmacology 9, 400679, 2018
262018
Molecular Characterization of the Burkholderia cenocepacia dcw Operon and FtsZ Interactors as New Targets for Novel Antimicrobial Design
G Trespidi, VC Scoffone, G Barbieri, G Riccardi, E De Rossi, S Buroni
Antibiotics 9 (12), 841, 2020
102020
Antistaphylococcal activity of the FtsZ inhibitor C109
G Trespidi, VC Scoffone, G Barbieri, F Marchesini, A Abualshaar, ...
Pathogens 10 (7), 886, 2021
72021
The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens
S Buroni, V Makarov, VC Scoffone, G Trespidi, G Riccardi, LR Chiarelli
European Journal of Medicinal Chemistry 190, 112132, 2020
72020
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia
LR Chiarelli, VC Scoffone, G Trespidi, G Barbieri, O Riabova, ...
Frontiers in Microbiology 11, 562, 2020
52020
Methodological tools to study species of the genus Burkholderia
VC Scoffone, G Trespidi, G Barbieri, S Irudal, A Israyilova, S Buroni
Applied Microbiology and Biotechnology, 1-16, 2021
32021
Identification by Reverse Vaccinology of Three Virulence Factors in Burkholderia cenocepacia That May Represent Ideal Vaccine Antigens
S Irudal, VC Scoffone, G Trespidi, G Barbieri, M D’Amato, S Viglio, ...
Vaccines 11 (6), 1039, 2023
22023
CodY is a global transcriptional regulator required for virulence in group B Streptococcus
A Pellegrini, G Lentini, A Famà, A Bonacorsi, VC Scoffone, S Buroni, ...
Frontiers in Microbiology 13, 881549, 2022
22022
Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against Acinetobacter baumannii
VC Scoffone, S Irudal, A AbuAlshaar, A Piazza, G Trespidi, G Barbieri, ...
Antibiotics 11 (11), 1571, 2022
12022
Characterization of the dispirotripiperazine derivative PDSTP as antibiotic adjuvant and antivirulence compound against Pseudomonas aeruginosa
A Bonacorsi, G Trespidi, VC Scoffone, S Irudal, G Barbieri, O Riabova, ...
Frontiers in Microbiology 15, 1357708, 2024
2024
New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis
VC Scoffone, G Barbieri, S Irudal, G Trespidi, S Buroni
Antibiotics 13 (1), 71, 2024
2024
Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against Acinetobacter baumannii. Antibiotics 2022, 11, 1571
VC Scoffone, S Irudal, A AbuAlshaar, A Piazza, G Trespidi, G Barbieri, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
2022
Molecular study of the Burkholderia cenocepacia division cell wall operon and FtsZ interactome as targets for new drugs
G Trespidi
Università degli studi di Pavia, 2021
2021
Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens. Antibiotics 2021, 10, 863
VC Scoffone, G Trespidi, G Barbieri, S Irudal, E Perrin, S Buroni
” The Structural and Functional Study of Efflux Pumps Belonging tothe RND …, 2021
2021
BURKHOLDERIA CENOCEPACIA DIVISOME AS A NEW TARGET TO HIT A RARE CYSTIC FIBROSIS PATHOGEN
V Scoffone, G Trespidi, L Chiarelli, G Manina, G Riccardi, S Buroni
PEDIATRIC PULMONOLOGY 54, S295-S295, 2019
2019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–18